Search and analyze individual stocks with comprehensive metrics

BETA Technologies, Inc Class A Common Stock

BETAPharmaceuticals
1720.70+0.00 (+0.00%)
As on 02 Jan 2026, 04:27 pmMarket Open

Fundamental Score

...

BETA Technologies, Inc Class A Common Stock Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Excellent

Return on Equity

25.86%
Excellent

Return on Capital Employed

27.04%
Excellent

Operating Profit Margin (5Y)

21.53%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

38.38x

Market Capitalization

1.74K (Cr)

Industry P/E

31.77x

Growth Metrics

Poor

YoY Quarterly Profit Growth

-2.13%
Poor

YoY Quarterly Sales Growth

12.92%
Excellent

Sales Growth (5Y)

31.89%
Excellent

EPS Growth (5Y)

37.15%
Excellent

Profit Growth (5Y)

37.14%

Financial Health

Poor

Debt to Equity

0.66x
Excellent

Interest Coverage

6.03x
Good

Free Cash Flow (5Y)

46.80 (Cr)

Ownership Structure

Good

Promoter Holding

66.73%
Poor

FII Holding

0.90%
Poor

DII Holding

0.29%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
66.73%
Promoter Holding
1.74K (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of BETA across key market metrics for learning purposes.

Positive Indicators

10 factors identified

Strong Return on Equity (25.86%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (27.04%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (21.53%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Consistent Growth Track Record (31.89% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Excellent EPS Growth (37.15% CAGR)

Observation: Outstanding 5-year earnings per share compound growth.

Analysis: EPS CAGR >15% indicates strong wealth creation potential and effective capital allocation over extended periods.

Strong Profit Growth Track Record (37.14% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Strong Interest Coverage (6.03x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk and strong debt servicing capability.

Strong Cash Generation (₹46.80 Cr over 5Y)

Observation: Healthy free cash flow generation supports growth and returns.

Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.

Balanced Promoter Holding (66.73%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

3 factors identified

Limited Institutional Interest (FII+DII: 1.19%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Loading Peer Comparison

Finding companies in the Pharmaceuticals sector...

Financial Statements

Comprehensive financial data for BETA Technologies, Inc Class A Common Stock

About BETA

Company Details

Symbol:BETA
Industry:Pharmaceuticals
Sector:Pharmaceuticals
Website:N/A

BETA Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)25.86%
Return on Capital Employed27.04%
Operating Profit Margin (5Y)21.53%
Debt to Equity Ratio0.66
Interest Coverage Ratio6.03

Growth & Valuation

Sales Growth (5Y)31.89%
Profit Growth (5Y)37.14%
EPS Growth (5Y)37.15%
YoY Quarterly Profit Growth-2.13%
YoY Quarterly Sales Growth12.92%

Frequently Asked Questions

What is the current price of BETA Technologies, Inc Class A Common Stock (BETA)?

As of 02 Jan 2026, 04:27 pm IST, BETA Technologies, Inc Class A Common Stock (BETA) is currently trading at ₹1720.70. The stock has a market capitalization of ₹1.74K (Cr).

Is BETA share price Overvalued or Undervalued?

BETA is currently trading at a P/E ratio of 38.38x, compared to the industry average of 31.77x. Based on this relative valuation, the stock appears to be Overvalued against its sector peers.

What factors affect the BETA Technologies, Inc Class A Common Stock share price?

Key factors influencing BETA's price include its quarterly earnings growth (Sales Growth: 12.92%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is BETA Technologies, Inc Class A Common Stock a good stock for long-term investment?

BETA Technologies, Inc Class A Common Stock shows a 5-year Profit Growth of 37.14% and an ROE of 25.86%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.66 before investing.

How does BETA Technologies, Inc Class A Common Stock compare with its industry peers?

BETA Technologies, Inc Class A Common Stock competes with major peers in the Pharmaceuticals. Investors should compare BETA's P/E of 38.38x and ROE of 25.86% against the industry averages to determine its competitive standing.

What is the P/E ratio of BETA and what does it mean?

BETA has a P/E ratio of 38.38x compared to the industry average of 31.77x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹38 for every ₹1 of annual earnings.

How is BETA performing according to Bull Run's analysis?

BETA has a Bull Run fundamental score of 61.2/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does BETA belong to?

BETA operates in the Pharmaceuticals industry. This classification helps understand the competitive landscape and sector-specific trends affecting BETA Technologies, Inc Class A Common Stock.

What is Return on Equity (ROE) and why is it important for BETA?

BETA has an ROE of 25.86%, which indicates excellent management efficiency and profitable operations. Return on Equity measures how efficiently BETA Technologies, Inc Class A Common Stock generates profits from shareholders' equity.

How is BETA's debt-to-equity ratio and what does it indicate?

BETA has a debt-to-equity ratio of 0.66, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is BETA's dividend yield and is it a good dividend stock?

BETA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has BETA grown over the past 5 years?

BETA has achieved 5-year growth rates of: Sales Growth 31.89%, Profit Growth 37.14%, and EPS Growth 37.15%.

What is the promoter holding in BETA and why does it matter?

Promoters hold 66.73% of BETA shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is BETA's market capitalization category?

BETA has a market capitalization of ₹1737 crores, placing it in the Small-cap category.

How volatile is BETA stock?

BETA has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for BETA?

BETA has a 52-week high of ₹N/A and low of ₹N/A.

What is BETA's operating profit margin trend?

BETA has a 5-year average Operating Profit Margin (OPM) of 21.53%, indicating the company's operational efficiency.

How is BETA's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 12.92% and YoY Profit Growth of -2.13%.

What is the institutional holding pattern in BETA?

BETA has FII holding of 0.90% and DII holding of 0.29%. Significant institutional holding often suggests professional confidence in the stock.